title: Is there a difference in the cost-effectiveness of erythropoietic therapies for the treatment of anemia in patients receiving HCV combination therapy?
authors.forename: Wenchen Kenneth
authors.initials: WK
authors.lastname: Wu
authors.forename: Mei Sheng
authors.initials: MS
authors.lastname: Duh
authors.forename: Patrick
authors.initials: P
authors.lastname: Lefebvre
mesh_terms: D000740:Anemia / Q000139:chemically induced* / Q000188:drug therapy*; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000191:economics / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000998:Antiviral Agents; D004921:Erythropoietin